[vc_row][vc_column][vc_column_text css=”.vc_custom_1654534364184{margin-bottom: 0px !important;}”]Our list of patents expiring from 2021 to 2025 was a blockbuster in the generic drug market.
With the huge growth in the generic drug market, there is no doubt that generic companies (you too?) are searching for drugs with a soon-to-be-expired label. So we decided to up our game further and extract all the drug patents expiring in this decade. So far we have published the drug patents expiring in 2026 and 2027. And today, I come bearing the list of drugs going off-patent in 2028.
To make their (your) work easy, we collected not just the drug names, but also included other information like yearly sales, treatment, ingredients, and the disease they cure which could help them (you) easily choose the drug most profitable to develop a generic version.
Without any delay, here is the list of drugs. Thank us later!
The article has a list of drug patents expiring in 2028. You can get the drug patents expiration list from 2026 to 2030 in a PDF by filling out the form below.
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][mk_fancy_title color=”#2878bf” size=”32″ line_height=”80″ font_weight=”bolder” txt_transform=”uppercase” margin_bottom=”0″ font_family=”none”]Drug Patents Expiring in 2028[/mk_fancy_title][mk_divider margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Mutamycin
Mitomycin[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9539241 | January 2, 2028 |
[/mk_table][vc_column_text css=”.vc_custom_1653319379289{margin-bottom: 0px !important;}”]Dosage: Intravenous Powder For Injection
Company: Biochem Pharmaceutical Industries
Ingredients: MITOMYCIN
Treatment: Upper Gastro-intestinal Cancers, Anal Cancers, and Breast Cancers[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Farydak
Panobinostat[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7989494 | January 17, 2028 |
[/mk_table][vc_column_text css=”.vc_custom_1653319481537{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Secura Bio
Ingredients: PANOBINOSTAT LACTATE
Treatment: Various Cancers[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Sivextro
Tedizolid[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8420676 | February 23, 2028 |
| US7816379 | June 20, 2028 |
| US9624250 | February 3, 2030 |
| US9624250 | February 3, 2030 |
| US8426389 | December 31, 2030 |
[/mk_table][vc_column_text css=”.vc_custom_1653319588116{margin-bottom: 0px !important;}”]Dosage: Oral, Intravenous
Company: Cubist Pharmaceuticals
Ingredients: TEDIZOLID PHOSPHATE
Treatment: Complicated Skin And Skin-structure Infections (CSSSIS)[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Xenleta
Lefamulin[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8153689 | March 19, 2028 |
| US8071643 | January 16, 2029 |
| US9120727 | May 23, 2031 |
[/mk_table][vc_column_text css=”.vc_custom_1653319668267{margin-bottom: 0px !important;}”]Dosage: Oral, Intravenous
Company: Nabriva Therapeutics
Ingredients: LEFAMULIN ACETATE
Treatment: Pneumonia[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Vosevi
Sofosbuvir/Velpatasvir/Voxilaprevir[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9585906 | March 21, 2028 |
| US8735372 | September 21, 2028 |
| US8889159 | September 26, 2029 |
| US9868745 | November 16, 2032 |
| US9296782 | July 17, 2034 |
[/mk_table][vc_column_text css=”.vc_custom_1653319808537{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Gilead Sciences
Ingredients: SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR
Treatment: Hepatitis C[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Zerbaxa
Ceftolozane/Tazobactam[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7129232 | May 15, 2028 |
| US8685957 | September 27, 2032 |
| US8476425 | September 27, 2032 |
| US8906898 | May 28, 2034 |
[/mk_table][vc_column_text css=”.vc_custom_1653319904251{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Merck & Co
Ingredients: CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
Treatment: Urinary Tract Infections[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Kybella
Deoxycholic Acid[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8242294 | May 16, 2028 |
[/mk_table][vc_column_text css=”.vc_custom_1653320029877{margin-bottom: 0px !important;}”]Dosage: Injections
Company: Kythera Biopharmaceuticals Inc
Ingredients: DEOXYCHOLIC ACID
Treatment: Double Chin[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Tepmetko
Tepotinib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8921357 | May 30, 2028 |
| US8329692 | October 30, 2029 |
| US8580781 | March 19, 2030 |
[/mk_table][vc_column_text css=”.vc_custom_1653320134973{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Emd Serono Inc
Ingredients: TEPOTINIB HYDROCHLORIDE
Treatment: Non-small Cell Lung Cancer (NSCLC)[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Kisqali
Ribociclib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8324225 | June 17, 2028 |
| US8415355 | August 21, 2029 |
| US8685980 | May 25, 2030 |
| US9193732 | November 9, 2031 |
[/mk_table][vc_column_text css=”.vc_custom_1653320229367{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Novartis Pharmaceuticals Corp
Ingredients: RIBOCICLIB SUCCINATE
Treatment: Breast Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Osmoprep
Sodium Phosphate Monobasic Monohydrate And Sodium Phosphate Dibasic Anhydrous[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7687075 | June 22, 2028 |
[/mk_table][vc_column_text css=”.vc_custom_1653320340841{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Salix Pharmaceuticals Inc
Ingredients: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Treatment: Constipation[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Rozlytrek
Entrectinib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9029356 | July 8, 2028 |
| US8299057 | March 1, 2029 |
| US9085565 | May 22, 2033 |
| US10738037 | May 18, 2037 |
[/mk_table][vc_column_text css=”.vc_custom_1653320444358{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Genentech Inc
Ingredients: ENTRECTINIB
Treatment: Non-small Cell Lung Cancer[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Minivelle
Estradiol[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9724310 | July 10, 2028 |
| US8231906 | July 4, 2030 |
[/mk_table][vc_column_text css=”.vc_custom_1653320517473{margin-bottom: 0px !important;}”]Dosage: Transdermal
Company: Noven Pharmaceuticals Inc
Ingredients: ESTRADIOL
Treatment: Menopause[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row]
[vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Truseltiq
Infigratinib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9067896 | August 6, 2028 |
| US8552002 | August 25, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653320590888{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Helsinn Healthcare Sa
Ingredients: INFIGRATINIB PHOSPHATE
Treatment: Cholangiocarcinoma[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Syndros
Dronabinol[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9345771 | August 6, 2028 |
| US8222292 | August 6, 2028 |
| US10265293 | August 6, 2028 |
| US11253472 | August 6, 2028 |
[/mk_table][vc_column_text css=”.vc_custom_1653320677425{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Benuvia Therapeutics Inc
Ingredients: DRONABINOL
Treatment: Nausea And Vomiting Caused By Chemotherapy[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Vizimpro
Dacomitinib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7772243 | August 26, 2028 |
[/mk_table][vc_column_text css=”.vc_custom_1653320777831{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Pfizer Inc
Ingredients: DACOMITINIB
Treatment: Non-small Cell Lung Cancer (NSCLC)[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Viekira Pak
Ombitasvir/Paritaprevir/Ritonavir[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8501238 | September 17, 2028 |
| US8188104 | May 17, 2029 |
| US8642538 | September 10, 2029 |
| US8420596 | April 10, 2031 |
| US8691938 | April 13, 2032 |
[/mk_table][vc_column_text css=”.vc_custom_1653320882457{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Abbvie Inc
Ingredients: DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
Treatment: Hepatitis C[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Epclusa
Sofosbuvir/Velpatasvir[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US8580765 | September 21, 2028 |
| US8334270 | September 21, 2028 |
| US9085573 | September 21, 2028 |
| US7964580 | September 26, 2029 |
| US8633309 | September 26, 2029 |
| US9284342 | March 13, 2031 |
| US8618076 | June 11, 2031 |
| US8575135 | May 16, 2033 |
| US8921341 | May 16, 2033 |
| US8940718 | May 16, 2033 |
[/mk_table][vc_column_text css=”.vc_custom_1653321038751{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Gilead Sciences Inc
Ingredients: SOFOSBUVIR; VELPATASVIR
Treatment: Hepatitis C[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Inqovi
Decitabine/Cedazuridine[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9567363 | October 16, 2028 |
| US8268800 | August 22, 2030 |
[/mk_table][vc_column_text css=”.vc_custom_1653321146139{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Otsuka Pharmaceutical Co Ltd
Ingredients: CEDAZURIDINE; DECITABINE
Treatment: Myelodysplastic Syndromes (MDS) And Chronic Myelomonocytic Leukemia (CMML)[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Erivedge
Vismodegib[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7888364 | November 11, 2028 |
[/mk_table][vc_column_text css=”.vc_custom_1653321210098{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Genentech Inc
Ingredients: VISMODEGIB
Treatment: Basal-cell Carcinoma (BCC)[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Zemdri
Plazomicin[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9688711 | November 21, 2028 |
| US8383596 | June 2, 2031 |
[/mk_table][vc_column_text css=”.vc_custom_1653321300288{margin-bottom: 0px !important;}”]Dosage: Intravenous
Company: Cipla USA Inc
Ingredients: PLAZOMICIN SULFATE
Treatment: Urinary Tract Infections[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Remodulin
Treprostinil[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US9604901 | December 15, 2028 |
| US9593066 | December 15, 2028 |
[/mk_table][vc_column_text css=”.vc_custom_1653321378005{margin-bottom: 0px !important;}”]Dosage: Intravenous, Subcutaneous
Company: United Therapeutics Corp
Ingredients: TREPROSTINIL
Treatment: Pulmonary Arterial Hypertension[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_row_inner][vc_column_inner width=”1/2″][mk_fancy_title color=”#777777″ size=”16″ font_family=”none”]Vraylar
Cariprazine[/mk_fancy_title][/vc_column_inner][/vc_row_inner][vc_accordions action_style=”toggle-action”][vc_accordion_tab icon=”mk-moon-inject-2″ title=”More information about this Drug”][vc_row_inner][vc_column_inner width=”1/12″][/vc_column_inner][vc_column_inner width=”10/12″][mk_table]
| Patents | Expiration Date |
|---|---|
| US7943621 | December 16, 2028 |
| US7737142 | September 17, 2029 |
[/mk_table][vc_column_text css=”.vc_custom_1653321463120{margin-bottom: 0px !important;}”]Dosage: Oral
Company: Allergan
Ingredients: CARIPRAZINE HYDROCHLORIDE
Treatment: Schizophrenia, Bipolar Mania, and Bipolar Depression[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/12″][/vc_column_inner][/vc_row_inner][/vc_accordion_tab][/vc_accordions][mk_divider style=”thin_solid” margin_bottom=”40″][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1654534540565{margin-bottom: 0px !important;}”]If you reached here, you are definitely looking for more! We know you, cos we are you. Just like you, we try to stay a step ahead of our competitors too. And so, our pharma team is working on its toes to extract all the drug patents expiring in the next 8 years from now. Want to get your hands on the complete list?[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_raw_html]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[/vc_raw_html][/vc_column][/vc_row][vc_row][vc_column][vc_column_text][/vc_column_text][/vc_column][/vc_row]
